NWBO
Price:
$0.252
Market Cap:
$314.56M
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.[Read more]
Industry
Biotechnology
IPO Date
2001-12-14
Stock Exchange
PNK
Ticker
NWBO
According to Northwest Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 367.25M. This represents a change of -53.12% compared to the average of 783.42M of the last 4 quarters.
The mean historical Enterprise Value of Northwest Biotherapeutics, Inc. over the last ten years is 435.71M. The current 367.25M Enterprise Value has changed 8.33% with respect to the historical average. Over the past ten years (40 quarters), NWBO's Enterprise Value was at its highest in in the September 2021 quarter at 5.08B. The Enterprise Value was at its lowest in in the June 2017 quarter at 65.36M.
Average
435.71M
Median
288.93M
Minimum
63.86M
Maximum
1.12B
Discovering the peaks and valleys of Northwest Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 722.19%
Maximum Annual Enterprise Value = 1.12B
Minimum Annual Increase = -74.31%
Minimum Annual Enterprise Value = 63.86M
Year | Enterprise Value | Change |
---|---|---|
2023 | 832.91M | 2.04% |
2022 | 816.22M | 28.70% |
2021 | 634.23M | -43.34% |
2020 | 1.12B | 722.19% |
2019 | 136.14M | 56.52% |
2018 | 86.98M | -2.92% |
2017 | 89.60M | 40.30% |
2016 | 63.86M | -74.31% |
2015 | 248.61M | -24.49% |
2014 | 329.25M | 208.79% |
The current Enterprise Value of Northwest Biotherapeutics, Inc. (NWBO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
761.12M
5-year avg
707.77M
10-year avg
435.71M
Northwest Biotherapeutics, Inc.’s Enterprise Value is greater than ImmunoCellular Therapeutics, Ltd. (15.86M), less than Celldex Therapeutics, Inc. (1.64B), greater than CEL-SCI Corporation (64.55M), greater than OncoSec Medical Incorporated (1.43M), greater than Advaxis, Inc. (4.59M),
Company | Enterprise Value | Market cap |
---|---|---|
15.86M | $15.86M | |
1.64B | $1.68B | |
64.55M | $52.80M | |
1.43M | $1.65M | |
4.59M | $1.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Northwest Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Northwest Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Northwest Biotherapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 3-year average Enterprise Value for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 5-year average Enterprise Value for Northwest Biotherapeutics, Inc. (NWBO)?
How does the current Enterprise Value for Northwest Biotherapeutics, Inc. (NWBO) compare to its historical average?